Efficacy data in perennial allergies

REACTINE® provided symptom relief vs placebo in patients with perennial allergic rhinitis (PAR)

Mean change from baseline in the total symptom severity complex (TSCC) score in a 4-week treatment period*

_{§P < 0.05, ‡P < 0.01. LS Mean = least squares mean.
Adapted from Skoner,}_{et al.}

Mean reduction from baseline in RQLQ scores over a 4- week treatment period

_{§P < 0.01. LS Mean = least squares mean.
Adapted from Skoner,}_{et al.}

*Based on a 4-week randomized, double-blind, placebo-controlled, parallel-group study of subjects with PAR (n=158 for the REACTINE® 10 mg group and n=163 for the placebo group).

References

^{1. Skoner, DP, LaForce, CL, Nathan, RA,}^{et al}^{. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis. Allergy Asthma Proc. 2014;35(4):338–345}